The effect of placenta previa on neonatal mortality: A population-based study in the United States, 1989 through 1997

• Published in: American journal of obstetrics and gynecology Vol. 188; no. 5; pp. 1299 - 1304
• Main Authors: Ananth, Cande V., Smulian, John C., Vintzileos, Anthony M.
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Mosby, Inc 01.05.2003; Elsevier
• Subjects: Adult; Analysis. Health state; Biological and medical sciences; birth weight; Cohort Studies; Diseases of mother, fetus and pregnancy; Epidemiology; Female; fetal growth restriction; General aspects; Gestational Age; Gynecology. Andrology. Obstetrics; Humans; Infant Mortality; Infant, Newborn; Medical sciences; Middle Aged; neonatal mortality; Placenta previa; Placenta Previa - mortality; Pregnancy; Pregnancy. Fetus. Placenta; Public health. Hygiene; Public health. Hygiene-occupational medicine; Retrospective Studies; United States - epidemiology; United States; birth weight; Placenta previa; gestational age; fetal growth restriction; neonatal mortality; Human; Intrauterine growth retardation; Neonatal; Pregnancy disorders; Mortality; Premature delivery; Placenta diseases; Epidemiology; Fetal diseases; Association; Newborn; Risk rate; Delivery disorders
• ISSN: 0002-9378; 1097-6868
• DOI: 10.1067/mob.2003.76

Objective: The purpose of the study was to explore the associations of placenta previa with preterm delivery, growth restriction, and neonatal survival. Study Design: A retrospective cohort study was performed of live births in the United States (1989-1991 and 1995-1997) that used the national linked birth/infant death records from 22,368,235 singleton pregnancies. The diagnosis of previa was restricted to those live births that were delivered (≥24 weeks) by cesarean delivery. We evaluated gestational age and birth weight-specific risk of neonatal deaths (within the first 28 days) in relation to placenta previa. Fetal growth was assessed in centiles of birth weight (<3rd, 3rd-4th, 5th-9th, 10th-90th, and >90th centile), adjusted for gestational age. All analyses were adjusted for the confounding effects of the year of delivery, maternal age, gravidity, education, prenatal care, marital status, and race/ethnicity. Results: Placenta previa was recorded in 2.8 per 1000 live births (n = 61,711). Neonatal mortality rate was 10.7 with previa, compared with 2.5 per 1,000 among other pregnancies (relative risk, 4.3; 95% confidence interval, 4.0,4.8). At 28 to 36 weeks, babies born to women with placenta previa weighed, on average, 210 g lower than babies born to women without placenta previa (P <.001). Compared with babies born to women without previa, the risk of death from placenta previa was lower among preterm babies (<37 weeks of gestation), with a crossover at 37 weeks where the mortality rate was higher for babies born to women with placenta previa than for babies born to women without placenta previa. This crossover also persisted in an analysis by birth weight and term births (delivered at ≥37 weeks of gestation). Mortality rates for term births were higher among babies born to women with placenta previa than among babies born women without placenta previa who were at the 10th to 90th centile (relative risk, 1.9; 95% confidence interval, 1.3, 2.8), and those at >90th centile (relative risk, 3.6; 95% confidence interval, 1.3, 9.6). Among preterm births, however, placenta previa was not associated with increased neonatal mortality by fetal growth centiles. Conclusion: The risk of neonatal mortality was higher for babies born to women with placenta previa than for babies born to women without placenta previa who were delivered at ≥37 weeks of gestation. Pregnancies that are diagnosed with placenta previa must be monitored carefully, especially as they approach term. (Am J Obstet Gynecol 2003;188:1299-1304.)